Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia

British Journal of Cancer

Volumn 77, Issue 2, 1998, Pages 277-286

  Gleeson, C M ^a   Sloan, J M ^b   McManus, D T ^b   Maxwell, P ^b   Arthur, K ^b   McGuigan, J A ^b   Ritchie, A J ^b   Russell, S E H ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Adenocarcinoma; Barrett's oesophagus; Gastric cardia; Oesophagus; p53

Indexed keywords

PROTEIN P53;

ARTICLE; BARRETT ESOPHAGUS; CARDIA; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; ESOPHAGUS CARCINOMA; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL; STATISTICS; STOMACH ADENOCARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0031985694     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.44     Document Type: Article

References (56)

1. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JKV, Hamilton S and Vogelstein B (1990) p53 gene mutations occur in combination with I7p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50: 7717-7722
2. Beahrs OH, Henson D, Hutter RVP and Myers MH (1988) Manual for Staging Cancer, American Joint Committee on Cancer. JB Lippincott: Philadelphia
3. Blot WJ, Devesa SS, Kneller RW and Fraumeni JK (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265: 1287-1289
4. Blount PL, Ramel S, Raskind WH, Haggitt RC, Sanchez CA, Dean PJ, Rabinovitch PS and Reid BJ (1991) 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Cancer Res 51: 5482-5486
5. Blount PL, Meltzer SJ, Yin J, Huang Y, Krasna MJ and Reid BJ (1993) Clonal ordering of 17p and 5q allelic losses in Barrett's dysplasia and adenocarcinoma Proc Natl Acad Sci USA 90: 3221-3225
6. Blount PL, Galipeau PC, Sanchez CA, Neshat K, Levine DS, Yin J, Suzuki H, Abraham JM, Meltzer SJ and Reid BJ (1994) 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res 54: 2292-2295
7. Brito MJ, Filipe MI, Williams GT, Thompson H, Omnerod MG and Titley J (1993) DNA ploidy in early gastric carcinoma (T1): a flow cytometric study of 100 European cases. Gut 34: 230-234
8. Carder P, Wyllie AH, Purdie C, Morris RG, White S, Piris J and Bird CC (1993) Stabilized p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 8: 1397-1401
9. Coulondre C, Miller JH, Farabaugh PJ and Gilbert W (1978) Molecular basis of base substitution hotspots in Escherichia coli. Nature 274: 775-780
10. Cripps KJ, Purdie CA, Carder PJ, White S, Komine K, Bird CC and Wyllie AH (1994) A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma. Oncogene 9: 2739-2743
11. Flejou J-F, Potet F, Muzeau F, Le Pelletier F, Fekete F and Henin D (1993) Overexpression of p53 protein in Barrett's syndrome with malignant transformation. J Clin Pathol 46: 330-333
12. Flejou J-F, Muzeau F, Potet F, Lepelletier F, Fekete F and Henin D (1994) Overexpression ot the p53 tumor suppressor gene product in esophageal and gastric carcinomas. Path Res Pract 190: 1141-1148
13. Gleeson CM, Sloan, JM, McGuigan JA, Ritchie AJ and Russell SEH (1995) Base transitions at CpG dinucleotides in the p53 gene are common in oesophageal adenocarcinoma. Cancer Res 55: 3406-3411
14. Greenblatt MS, Bennett WP, Hollstein M and Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878
15. Gyapay G, Morissette J, Vignal A, Dib C, Bernardi G, Lathrop M and Weissenbach J (1994) The 1993-1994 Genethon human genetic linkage map. Nature Genet 7: 246-339
16. Haggitt RC, Reid BJ, Rabinovitch PS and Rubin CE (1988) Barrett's esophagus: correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol 131: 53-61
17. Hamelin R, Flejou J-F, Muzeau F, Potet F, Laurent-Puig P, Fekete F and Thomas G (1994) TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology 107: 1012-1018
18. Hardwick RH, Shepherd NA, Moorghen M, Newcomb PV and Alderson D (1994) Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut 35: 764-768
19. Hedley DW, Friedlander ML, Taylor IW, Rugg CA and Musgrove EA (1983) Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. J Cytochem 31: 1333-1335
20. Hermanek P and Sobin LH (1987) Classification of Malignant Tumors. Springer: Berlin
21. Hongyo T, Buzard GS, Palli D, Weghorst CM, Amorosi A, Galli M, Caporaso NE, Fraumeni JF and Rice JM (1995) Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res 55: 2665-2672
22. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ and Harris CC (1991) Mutational hotspot in the P53 gene in human hepatocellular carcinomas. Nature 350: 427-428
23. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, Reid BJ and Meltzer SJ (1992) Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 52: 6526-6530
24. Johnson H, Belluco C, Masood S, Abou-Azama AM, Kahn L and Wise L (1993) The value of flow cytometric analysis in patients with gastric cancer. Arch Surg 128: 314-317
25. Kalish RJ, Clancy PE, Orringer MB and Appelman HD (1984) Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia. Gatroenterology 86: 461-467
26. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311
27. Krishnadath KK, Tilanus HW, Van Blankenstein M, Bosman FT and Mulder AH (1995) Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol 175: 175-180
28. Lauren P (1965) The two histological main types of gastric adenocarcinoma: diffuse and so-called intestinal-type adenocarcinonia. Acta Pathol Microbiol Immunol Scand 5: 145-153
29. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tisty TD (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935
30. Martin HM, Filipe MI, Morris RW, Lane DP and Silvestre F (1992) p53 expression and prognosis in gastric carcinoma. Int J Cancer 50: 859-862
31. Martinez J, Georgoff I, Martinez J and Levine AJ (1991) Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5: 151-159
32. McBride OW, Merry D and Givol D (1986) The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci USA 83: 130-134
33. Nakamura T, Nekarda H, Hoelscher AH, Bollschweiler E, Harbeck N, Becker K, Sieweri JR and Harbeck H (1994) Prognostic value of DNA ploidy and c-erhB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus. Cancer 73: 1785-1794
34. Neshat K, Sanchez CA, Galipeau PC, Blount PL, Levine DS, Joslyn G and Reid BJ (1994) p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 106: 1589-1595
35. Offerhaus GJA, De Feyter EP, Cornelisse CJ, Tersmette KWF, Floyd J, Kern SE, Vogelstein B and Hamilton SR (1992) The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma. Gastroenterology 102: 1612-1619
36. Oliphant AR, Wright EC, Swensen J, Gruis NA, Goldgar D and Skolnick MH (1990) Dinucleotide repeat polymorphism at the D17S513 locus. Nucleic Acids Res 19: 4794
37. Powell J and McConkey CC (1990) Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 62: 440-443
38. Ranzani GN, Renault B, Pellegata NS, Fattorini P, Magni E, Bacci F and Amadori D (1993) Loss of heterozygosity and K-ras gene mutations in gastric cancer. Hum Genet 92: 244-249
39. Reid BJ, Haggitt RC, Rubin CE and Rabinovich PS (1987) Barrett's esophagus: correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 93: 1-11
40. Renault B, Van Den Broek M, Fodde R, Wijnen J, Pellegata NS, Amadori D, Khan PM and Ranzani GN (1993) Base transitions are the most frequent changes at p53 in gastric cancer. Cancer Res 53: 2614-2617
41. Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, Nakamura Y, Kajiyama G and Tahara E (1991) Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas Cancer Res 51: 2926-2931
42. Seruca R, David L, Holm R, Nesland JM, Fangan BM, Castedo S, Sobrinho-Simoes M and Borresen A-L (1992) p53 mutations in gastric carcinomas. Br J Cancer 65: 708-710
43. Shiao Y-H, Rugge M, Correa P, Lehmann HP and Scheer WD (1994) p53 alterations in gastric precancerous lesions. Am J Pathol 144: 511-517
44. Sidoni A, Lancia D, Pietropaoli N and Ferri I (1989) Changing patterns in gastric carcinoma. Tumori 75: 605-608
45. Soussi T, De Fromentel CC and May P (1990) Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5: 945-952
46. Spechler SJ, Robbins AH, Bloomfield Rubins H, Vincent ME, Heeren T, Doos WG, Colton T and Schimmel EM (1984) Adenocarcinoma and Barrett's esophagus: an overrated risk? Gastroenterology 87: 927-933
47. Thilly WG (1990) Mutational spectrometry in animal toxicity testing. Annu Rev Pharmacol Toxicol 30: 369-385
48. Thompson JJ, Zinsser KR and Enterline HT (1983) Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum Pathol 14: 42-61
49. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M and Hirohashi S (1993) p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 54: 759-764
50. Wang HH, Antonioli DA and Goldman H (1986) Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency. Hum Pathol 17: 482-487
51. Winters C, SpurlingTJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker III JF, Johnson DA, Cruess DF, Cotelingam JD, Gurney MS and Cattau Jr EL (1987) Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92: 118-124
52. Wu X, Bayle JH, Olson D and Levine AJ (1993) The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7: 1126-1132
53. Wynford-Thomas D (1992) p53 in tumour pathology: can we trust immunocytochemistry? J Pathol 166: 329-330
54. Yew PR and Berk AJ (1992) Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357: 82-85
55. Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937-948
56. Yonemura Y, Ohoyama S, Kimura H, Matumoto H, Ninomiya I, Kosaka T, Yamaguchi A, Miwa K and Miyazaki I (1992) Independent clinical and flow cytometric prognostic factors for the survival of patients with stage I gastric cancer. Surg Today 22: 416-420